139 related articles for article (PubMed ID: 8467356)
1. Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
Widdop RE; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Mar; 108(3):684-8. PubMed ID: 8467356
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Gardiner SM; March JE; Kemp PA; Mullins JJ; Bennett T
Br J Pharmacol; 1995 Oct; 116(4):2237-44. PubMed ID: 8564254
[TBL] [Abstract][Full Text] [Related]
3. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
Batin P; Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Jun; 103(2):1585-91. PubMed ID: 1884112
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
Widdop RE; Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 Nov; 107(3):873-80. PubMed ID: 1472980
[TBL] [Abstract][Full Text] [Related]
5. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
[TBL] [Abstract][Full Text] [Related]
6. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats.
Li XC; Widdop RE
Clin Sci (Lond); 1996 Aug; 91(2):147-54. PubMed ID: 8795437
[TBL] [Abstract][Full Text] [Related]
8. Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
Gardiner SM; March JE; Kemp PA; Bennett T
Br J Pharmacol; 1996 May; 118(2):325-34. PubMed ID: 8735634
[TBL] [Abstract][Full Text] [Related]
9. Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats.
Batin P; Gardiner SM; Compton AM; Bennett T
Life Sci; 1991; 48(8):733-9. PubMed ID: 1994182
[TBL] [Abstract][Full Text] [Related]
10. Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 Aug; 118(7):1822-8. PubMed ID: 8842449
[TBL] [Abstract][Full Text] [Related]
11. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
12. Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(1):141-9. PubMed ID: 8733587
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
14. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats.
Widdop RE; Gardiner SM; Bennett T
Brain Res; 1994 Jun; 648(1):46-52. PubMed ID: 7922526
[TBL] [Abstract][Full Text] [Related]
16. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.
Gardiner SM; Compton AM; Bennett T
Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584
[TBL] [Abstract][Full Text] [Related]
17. Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats.
Waller J; Gardiner SM; Bennett T
Br J Pharmacol; 1994 Aug; 112(4):1057-64. PubMed ID: 7952864
[TBL] [Abstract][Full Text] [Related]
18. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1993 Sep; 110(1):159-62. PubMed ID: 8220876
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs.
Brooks DP; Fredrickson TA; Weinstock J; Ruffolo RR; Edwards RM; Gellai M
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):673-8. PubMed ID: 1635591
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
